Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D09XGB
|
|||
Former ID |
DNC002370
|
|||
Drug Name |
VER 50589
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Breast cancer [ICD-11: 2C60-2C65] | Phase 2 | [1] | |
Therapeutic Class |
Anticancer Agents
|
|||
Structure |
Download2D MOL |
|||
Formula |
C19H17ClN2O5
|
|||
Canonical SMILES |
CCNC(=O)C1=NOC(=C1C2=CC=C(C=C2)OC)C3=CC(=C(C=C3O)O)Cl
|
|||
InChI |
1S/C19H17ClN2O5/c1-3-21-19(25)17-16(10-4-6-11(26-2)7-5-10)18(27-22-17)12-8-13(20)15(24)9-14(12)23/h4-9,23-24H,3H2,1-2H3,(H,21,25)
|
|||
InChIKey |
JXPCDMPJCKNLBY-UHFFFAOYSA-N
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
References | Top | |||
---|---|---|---|---|
REF 1 | The HSP90 inhibitor NVP-AUY922 potently inhibits non-small cell lung cancer growth. Mol Cancer Ther. 2013 Jun;12(6):890-900. | |||
REF 2 | Recent advances in Hsp90 inhibitors as antitumor agents. Anticancer Agents Med Chem. 2008 Oct;8(7):761-82. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.